Clinical trial
Modulation of Arachidonic Acid Metabolism by Chemopreventive Agents in Smokers
NCT01021215 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Arachidonic Acid Metabolism by Chemopreventive Agents in Smokers
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- March 31, 2013
- Enrollment
- 84 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.